Related Experiment Videos

Interventional Potential of Panax Genus Chinese Medicinals in Atherosclerosis Progression

Wenjing Li1, Haiyan Li2, Ronghua Zhao1

  • 1Northeast Asia Institute of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, Jilin, China.

Insights

Medicinal herbs from the Araliaceae family show promise in combating atherosclerosis. This review details their protective effects and mechanisms against this global health challenge.

Area of Science:

  • Cardiovascular Research
  • Pharmacology
  • Herbal Medicine

Background:

  • Atherosclerosis is a major global health concern with complex causes, including lipid abnormalities, immune responses, and inflammation.
  • Current preventive and therapeutic strategies for atherosclerosis are insufficient.
  • Herbs from the Araliaceae family, such as Panax ginseng, exhibit potential anti-atherosclerotic properties.

Purpose of the Study:

  • To comprehensively review and update the protective effects of Araliaceae herbs against atherosclerosis.
  • To elucidate the underlying pharmacological mechanisms of these herbs in preventing and treating atherosclerosis.

Main Methods:

  • Literature review of studies on Araliaceae herbs and atherosclerosis.
  • Analysis of pharmacological actions including lipid metabolism, immune modulation, and anti-inflammatory effects.
  • Examination of impacts on endothelial function, cell processes, and gut microbiota.

Main Results:

  • Araliaceae herbs demonstrate multifaceted protective effects against atherosclerosis.
  • Key mechanisms include regulating lipid metabolism, modulating immune cell activation, and reducing inflammation.
  • These herbs also impact oxidative stress, endothelial function, cell proliferation, angiogenesis, apoptosis, autophagy, and gut microbiota.

Conclusions:

  • Herbs from the Araliaceae family offer significant therapeutic potential for atherosclerosis.
  • Their mechanisms involve a wide range of biological processes crucial for cardiovascular health.
  • Further research into Araliaceae herbs could lead to novel strategies for managing atherosclerosis.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...